RANDOMIZED, MULTICENTER TACROLIMUS WITH STEROID VS STEROID FREE (SNS-01)

随机、多中心他克莫司含类固醇与不含类固醇 (SNS-01)

• 批准号: 7607268
• 负责人: WILLIAM E. HARMON
• 金额: $ 2.39万
• 依托单位: BOSTON CHILDREN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607268
• 关键词: Computer Retrieval of Information on Scientific Projects Database; Daclizumab; Funding; Grant; Institution; Prograf; Protocols documentation; Randomized; Research; Research Personnel; Resources; Safety; Source; Standards of Weights and Measures; Steroids; Tacrolimus; Transplantation; United States National Institutes of Health; base; fluorouracil/methotrexate/mitoxantrone protocol; mycophenolate mofetil

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The study objective is to compare the safety and efficacy of a traditional steroid based-protocol (Prograf, MMF, steroids and standard daclizumab induction until the second month post-transplant) to a steroid-free protocol (Prograf, MMF and daclizumab induction until the sixth month post-transplant).

这个子项目是众多研究子项目之一